Role of Ultrasound in Diagnosis of Placenta Previa and MAP

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Morbidly Adherent Placenta Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Placenta Accreta Placenta Diseases Pregnancy Complications Urogenital Diseases

Age range

20 year–43 year

Sex eligibility

Female

Study type

Observational

Primary location

Algazeerah

Giza, Egypt

About this study

The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

pregnant ladies with previous cesarean sections
GA above 30 weeks

Exclusion criteria

Primigravida patients
GA below 30 weeks

Treatment and study plan

Primary outcomes

number of participants who will be diagnosed to have normal placenta or placenta previa or morbidly adherent placenta by US

Time frame: within 6 weeks

Sponsors and collaborators

Lead sponsor

Aljazeera Hospital

Other

Collaborators

Cairo University
National Research Centre, Egypt

Registry information

Official study title

Evaluation of Role of Ultrasound TA,TV,TP in Diagnosis of Placenta Previa and MAP(Morbidly Adherent Placenta )

Important dates

Study start: 2018
Primary completion: 2019
Study completion: 2019
First posted: Jan 31, 2018
Registry last updated: Sep 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed